SCHEMBL10079286

SCHEMBL10079286

CC(C)[C@H]1CCC[C@H]2OC[C@@H](C)N2C1=O

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FAP Q12884 2/20 0.31
PER2 O15055 1/20 0.30
CRY2 Q49AN0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10060266 0.86 FAP (0.32) FAPPER2CRY2
SCHEMBL10060257 0.81 FAP (0.31) FAP
SCHEMBL10060269 0.79 FAP (0.36) FAP
SCHEMBL10079279 0.75 FAP (0.31) FAP
SCHEMBL10060267 0.74 FAP (0.36) FAP
SCHEMBL15468303 0.73 FAP (0.39) FAP
SCHEMBL10079285 0.72 MAPK1 (0.36)
SCHEMBL10060275 0.70 PIK3CD (0.30)
SCHEMBL11952915 0.69 MAPK1 (0.36)
SCHEMBL10060274 0.69 PIK3CD (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163792-B2 IAP BIR domain binding compounds PHARMASCIENCE INC. (CA) 2012-04-24 US disclosed
US-20090192140-A1 IAP BIR DOMAIN BINDING COMPOUNDS AEGERA THERAPEUTICS INC. (CA) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192140-A1 IAP BIR DOMAIN BINDING COMPOUNDS BIRC5, BIRC2, BIRC3 FAP 228/4885PER2 4770/4885CRY2 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.